Cite
MLA Citation
C. Clark et al.. “Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy.” Bone marrow transplantation, vol. 53, 2018, pp. 1589–1592. http://access.bl.uk/ark:/81055/vdc_100099701082.0x000231